December 07, 2017
Event Driven, a Reorg Research product, offers real-time news and analysis on market-moving litigations, public policy changes and M&A enforcement for investors, traders and lawyers.
Antitrust Risk & Market Impact of the AET/CVS Merger: On-Demand Webinar
Event Driven hosted a 50-minute webinar on Wednesday, Dec. 6, 2017 discussing CVS’s bold play for Aetna. During the webinar, the Event Driven team and industry experts discussed the antitrust risk and market impact of this merger, how it fits into the DOJ’s new antitrust policies, whether it will be impacted by the ongoing battles in D.C. over the repeal and replacement of Obamacare and what changes and potential other mergers could be triggered by the deal.
Panelists included:
- Andrew Lowenthal , Congressional Analyst, Event Driven (Moderator)
- Nils Tracy , Senior Analyst, Event Driven
- Spencer Perlman , Managing Partner & Director of Healthcare Research, Veda Partners
More from Event Driven
The most important insight of the day
Get the Harvest Daily Digest newsletter.